From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief […]
Zynex Inc.
NuVasive co-founder McKinley is Vascular Dynamics new COO | Personnel Moves June 9, 2016
NuVasive co-founder McKinley is Vascular Dynamics new COO Vascular Dynamics said it tapped NuVasive Inc. (NSDQ:NUVA) co-founder and former CEO James McKinley as its new chief operating officer. McKinley has held leadership positions at Advent Medical, Endosphere, Farallon Medical and Nellix, as well as NuVasive. “It is a tremendous opportunity to add Jim to our management team. […]
InspireMD lifts COO Barry to the corner office | Personnel Moves June 8, 2016
InspireMD lifts COO Barry to the corner office InspireMD (OTC:NSPR) said yesterday it promoted COO Dr. James Barry to the office of CEO and president, effectively immediately. Former CEO Alan Milinazzo announced he would step down from the position in January. “We are extremely pleased to name Dr. Barry as President and CEO. Jim brings an […]
Zynex wins Russian approval for NexWave and NeuroMove devices
Zynex CEO clears out board | Personnel Moves
Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.
Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard’s vision for the rehab devices maker.
Rehab devices maker Zynex signs distribution deal in China
FDA grants Zynex 510(k) clearance for female incontinence device
Colorado-based device maker Zynex (OTC:ZYXI) won FDA clearance for its InWave device, an electrotherapy system for treating female urinary incontinence.
The company’s hoping that the InWave device will complement its existing electrotherapy portfolio and spur a boost in revenue, CEO Thomas Sandgaard said in a press release.
Accuray slides on lowered sales outlook | Earnings Roundup
Accuray (NSDQ:ARAY) shares are down nearly 10% today as investors react to wider 3rd-quarter losses and a lower sales forecast for the rest of fiscal 2012.
The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.
Sorin’s 2011 sales stay flat, profits soar | Earnings Roundup
Sorin Group (BIT:SRN) reported flat sales but strong profit growth for 2011, saying it raised earnings by 48.3% and revealing that the cardiac rhythm management slump has made its way across the pond.
The Italian medical device maker posted net income of €58.0 million (~$75.2 million) on sales of €743.4 million (~$963.4 million) for the year ended Dec. 31, 2011. That compares with profits of €39.1 million (~$50.7 million) on sales of €745.8 million (~$966.5 million) during 2010.
Standard & Poor’s gives Medtronic an A+ | Wall Street Beat
Standard & Poor’s Ratings Services affirmed Medtronic’s (NYSE:MDT) long-term debt’s “A+” rating yesterday, after the med-tech titan announced another debt offering.
The rating agency said its view of Medtronic’s senior unsecured notes and its stable rating outlook “reflect the company’s ‘strong’ business risk profile and ‘modest’ financial risk profile.”
Masimo picks up LED maker Spire Semiconductor for undisclosed amount | MassDevice.com On Call
MASSDEVICE ON CALL — Masimo (NSDQ:MASI) nabbed light-emitting diode-maker Spire Semiconductor LLC for an undisclosed amount in a move aimed at cutting costs, speeding development and spurring innovation.
Spire’s advanced LED technology was spun into a wholly owned Hudson, N.H.-based subsidiary named Masimo Semiconductor, which will develop custom components for Masimo’s devices as well as for biomedical, telecommunications, consumer products and other markets, according to a press release.
